This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Learn effective ways to use your reward points to get the most out of your credit card benefits. Start maximizing your rewards now!
23,429 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Oracle has fallen this year as investors weigh legacy strengths against AI disruption. This guide breaks down the AI ...
Policy headwinds aren’t the end of the story for solar investors. This guide explains how AI-driven demand, select co...
Investing in high-growth EV names can be tempting when share prices dip. This guide helps you evaluate should rivian ...
Starting with your first no annual fee card? This guide breaks down the 2023 best no annual fee cards for beginners, ...
Leveraged ETFs can move markets fast, but that speed cuts both ways. This guide explains how they work, the risks of ...
Nokomis Capital quietly builds a new position in Apple Hospitality REIT, underscoring a rising appetite for hospitali...
Nio delivered a staggering 129% jump in EV sales, yet its stock slid in May. This analysis breaks down the drivers be...
A major reinsurance renewal helped Lemonade rewrite its profit picture, sending LMND higher in a short week. Here’s w...
Jamie Dimon argues that insecurity is the real career killer for CEOs as they move from specialists to generalists. T...
Rocket Lab is shaping the small-launch landscape, and the company’s 2025 earnings story matters for investors. This g...
Warren Buffett’s transition at Berkshire Hathaway puts Apple in the spotlight as the conglomerate’s largest public ho...